Table 1 Clinicopathological features of patients
| Median (range) | |
|---|---|
| Age | 66 (52–74) |
| Preoperative serum PSA (ng/ml) | 10.3 (0.2-118.0) |
| % (n) | |
| Preoperative serum PSA | |
| <10 ng/ml | 41.7 (35) |
| ≥10 ng/ml | 58.3 (49) |
| Gleason score | |
| <7 | 28.6 (24) |
| 7 | 47.6 (40) |
| >7 | 23.8 (20) |
| Clinical T stage | |
| I | 56 (47) |
| II | 44 (37) |
| Pathological T stage | |
| II | 64.3 (54) |
| III | 32.1 (27) |
| IV | 3.6 (3) |
| Node involvement | 7.1 (6) |
| Positive surgical margins | 41.7 (35) |
| Perineural invasion | 17.9 (15) |
| Total Biochemical progression | 40.5 (34) |
| at 5 years | 38.1 (32) |
| 5 - 10 years | 2.4 (2) |
| Survival | 64.7a(22) |
| Deaths | 35.3a(12) |
